# Konapharma AG – FDA Inspection, Jun 22, 2018

Source: https://www.keypedia.com/records/fda_inspections/konapharma-ag/fcc2ab15-1bae-4ee9-9ceb-c3d7c155af3c
Source feed: FDA_Inspections

> FDA inspection 1059703 of Konapharma AG, June 22, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059703
- Company Name: Konapharma AG
- Inspection Date: 2018-06-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1257699 - 2024-06-19
- FDA Inspection 957960 - 2016-01-22
- FDA Inspection 827273 - 2013-04-17
- FDA Inspection 619086 - 2009-09-15

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/noreen-muniz/0bb20d12-62ad-42aa-8b0a-c44b339d413f)

Company: https://www.keypedia.com/companies/konapharma-ag/1ef1b930-e6b0-4f43-ae72-44e971cdfa84

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c